BridgeMD
New treatment option for Stroke
Official title Effect of HIIT on Post-Stroke Fatigue
ClinicalTrials.gov ID: NCT07273058
What this study is testing
- What it's testing
- This study aims to investigate the effect of high-intensity interval training (HIIT) on fatigue severity among individuals with chronic stroke. Participants will be randomly assigned to the HIIT group, the moderate-intensity continuous training (MICT) group, or the stretching group (active control).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 80
You may be able to join if
- Age of 40-80 years;
- a history of ischemic stroke resulting in unilateral limb impairment 6-60 months prior to consent to participate in the pilot trial;
- a stable medical condition;
- a subjective feeling of fatigue, defined as a period of apparent fatigue, decreased energy, increased need for rest, or fatigue out of proportion to...
- ability to communicate with the investigators and lack of significant cognitive deficits;
You likely can't join if
- An FSS score of \< 4 (20);
- other neurological conditions;
- other musculoskeletal comorbidities that would prevent safe participation in exercises;
- a medical diagnosis of significant cardiovascular, pulmonary, or metabolic disease(s);
- signs or symptoms indicative of significant cardiovascular, pulmonary, or metabolic disease(s) during the previous 3 months;
- severe lower limb spasticity (Ashworth Scale score ≥ 3);
See the full eligibility criteria
- Age of 40-80 years;
- a history of ischemic stroke resulting in unilateral limb impairment 6-60 months prior to consent to participate in the pilot trial;
- a stable medical condition;
- a subjective feeling of fatigue, defined as a period of apparent fatigue, decreased energy, increased need for rest, or fatigue out of proportion to physical activity for at least 2 weeks during the past month;
- ability to communicate with the investigators and lack of significant cognitive deficits;
- able to walk for 10 meters with or without a walking aid.
- An FSS score of \< 4 (20);
- other neurological conditions;
- other musculoskeletal comorbidities that would prevent safe participation in exercises;
- a medical diagnosis of significant cardiovascular, pulmonary, or metabolic disease(s);
- signs or symptoms indicative of significant cardiovascular, pulmonary, or metabolic disease(s) during the previous 3 months;
- severe lower limb spasticity (Ashworth Scale score ≥ 3);
- Botulinum toxin use in the affected lower limb within the past six months;
- current or previous use of drugs intended to resolve post-stroke fatigue;
- active engagement in other stroke rehabilitation trials.
The study team makes the final eligibility decision.
Where it's taking place
- Kowloon, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kowloon, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.